The future of molecular diagnostics lies with NAATs and NGS that can rapidly provide definitive and actionable results for the detection of bacterial diseases with better sensitivity.
Analyzers with novel technologies may soon emerge to push the molecular diagnostics laboratory into yet another stage of evolution
Molecular diagnostics is transforming healthcare, and analyzers with novel technologies may soon emerge to push the molecular diagnostic laboratory into yet another stage of evolution.
The increasing use of molecular diagnostic technologies in research and development coupled with rising demand for point-of-care and OTC and self-test products is providing the requisite impetus.
In 2014, only one system was purchased, and in spite of a growing market, all others had to be placed.
Buying seems to be passé. The molecular diagnostics industry is a case in point, where in 2014, only 1 system was purchased, and in spite of a growing market, all the others had to be placed. And yet we see new players enter the Indian market.
Manufacturers have focused on simplifying and automating both specimen extraction and nucleic acid detection steps to deliver better molecular diagnostics products.
The advent of automated molecular diagnostic analyzers is paving the way for rapid growth and expansion of molecular laboratories.